Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share

May 15, 2012 9:05 AM

Cardium Therapeutics, Inc. (NYSE: CXM) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.

For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.

No results found